The Blog

Marketing Rx

Telehealth marketing insights from a physician who does both. No fluff. No agency speak. Just what works.

Apr 13, 2026

Why GLP-1 telehealth compliance is becoming the real moat

GLP-1 telehealth compliance is becoming a growth moat. Learn how claims discipline, pharmacy relationships, platform risk, and partner trust now shape long-term survival.

The agency business model is broken. Here's how it actually works.

Agencies sell senior people in the pitch, then staff juniors on the work. The margin math, utilization traps, and 5 questions to ask before signing.

How do I market my GLP-1 telehealth company without running into FDA or FTC problems?

FDA sent thousands of warning letters in 2025 targeting GLP-1 claims. What you can and can't say about semaglutide, compounding, and weight loss.

Why your marketing agency is optimizing for their renewal, not your results

Agency economics favor 'good enough' results over great ones. Learn how the retainer model creates misaligned incentives and how to restructure the relationship.

How do I find a marketing agency for my telehealth startup that actually understands FDA and FTC rules?

Most agencies that say they 'do healthcare' mean hospitals, not telehealth. Learn the 4 compliance frameworks and 4 vetting questions before you hire.